Results 181 to 190 of about 47,188 (263)

A Systemic Review and Network Meta-Analysis of Cardiovascular Safety of Benzbromarone, Febuxostat, and Allopurinol in Patients with Gout [PDF]

Ting Syuan Lin, Yen Liang Lin, Chiu Hao Hsu, Song Chou Hsieh, W.Y. Shau, Wei Shiung Yang, Chih Ling Chen   +6 more
openalex   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source

Rasburicase vs. allopurinol: mortality in hematological malignancies post anti-hyperuricemic therapy - real-world study. [PDF]

Support Care Cancer
Cairo MS, Gallagher JR, Barnes Y, Drea E, Clark C, Carroll S.   +5 more
europepmc   +1 more source

Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]

Nephrology (Carlton)
Inoue R, Yamaguchi S, Okada A, Yamauchi T, Kadowaki T, Nangaku M.   +5 more
europepmc   +1 more source

Mechanism of xanthine oxidase in flap ischemia-reperfusion injury and advances in targeted therapy: a mini review. [PDF]

Front Physiol
Jia W, Wei X, Gong X.
europepmc   +1 more source

Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort. [PDF]

Balkan Med J
Ahsaan F, Latif B, Rehman Z.
europepmc   +1 more source

Laporan kasus: eritroderma akibat reaksi alergi obat allopurinol

Daffa Nissa, Dian Kusuma Ramadhan
openalex   +2 more sources

Cost-Effectiveness of Low-Dose Colchicine Prophylaxis When Starting Allopurinol Using the "Start-Low Go-Slow" Approach for Gout: Evidence From a Noninferiority Randomized Double-Blind Placebo-Controlled Trial. [PDF]

Arthritis Care Res (Hoboken)
Pryymachenko Y, Wilson R, Dalbeth N, Abbott JH, Stamp L.   +4 more
europepmc   +1 more source